Loading
Latest filing published 18 Jun 2026 for enGene Therapeutics Inc.. Read the official filing
No signal scores available.
Philip Astley-Sparke has a single filing on record, published on 18 June 2026: an option exercise in enGene Therapeutics Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration